Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)

NAActive, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 4, 2018

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Barrett EsophagusIntestinal MetaplasiaEsophageal Dysplasia
Interventions
DEVICE

CryoBalloon Focal Ablation System

CryoBalloon Focal Ablation System

Trial Locations (11)

10032

Columbia University, New York

11042

Northwell Health, Lake Success

17822

Geisinger Clinic, Danville

20057

Georgetown University, Washington D.C.

21205

Johns Hopkins University, Baltimore

27599

UNC Chapel Hill, Chapel Hill

29425

Medical University of South Carolina, Charleston

35294

University of Alabama at Birmingham, Birmingham

44106

University Hospitals Cleveland Medical Center, Cleveland

55905

Mayo Clinic Rochester, Rochester

77030

UTHealth Science Center/Herman Memorial, Houston

All Listed Sponsors
collaborator

PENTAX of America, Inc.

UNKNOWN

collaborator

Johns Hopkins University

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT03554356 - Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE) | Biotech Hunter | Biotech Hunter